图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

ISSN:1381-3455
出版频率:Bi-monthly
出版社:TAYLOR & FRANCIS LTD, 2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN
  出版社网址:http://www.tandf.co.uk/libsite/
期刊网址:http://informahealthcare.com/loi/arp
影响因子:4.076
主题范畴:ENDOCRINOLOGY & METABOLISM;    PHYSIOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

 

Editor-in-Chief: Jürgen Eckel
Five issues are published per year.
ISSN: 1381-3455 (print), 1744-4160 (electronic)



Read More: http://informahealthcare.com/loi/arp
Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.

The scope encompasses all topics related to the molecular and cellular pathophysiology of metabolic diseases like obesity, type 2 diabetes and the metabolic syndrome, and their associated complications.

Clinical studies are considered as an integral part of the Journal and should be related to one of the following topics:
  • the dysregulation of hormone receptors and signal transduction
  • the contribution of gene variants and gene regulatory processes
  • the impairment of intermediary metabolism at the cellular level
  • secretion and metabolism of peptides and other factors that mediate cellular crosstalk
  • therapeutic strategies for managing metabolic diseases

Special issues dedicated to topics in the field will be published regularly.





Read More: http://informahealthcare.com/page/arp/Description#Instructions
Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.

The scope encompasses all topics related to the molecular and cellular pathophysiology of metabolic diseases like obesity, type 2 diabetes and the metabolic syndrome, and their associated complications.

Clinical studies are considered as an integral part of the Journal and should be related to one of the following topics:
  • the dysregulation of hormone receptors and signal transduction
  • the contribution of gene variants and gene regulatory processes
  • the impairment of intermediary metabolism at the cellular level
  • secretion and metabolism of peptides and other factors that mediate cellular crosstalk
  • therapeutic strategies for managing metabolic diseases

Special issues dedicated to topics in the field will be published regularly.





Read More: http://informahealthcare.com/page/arp/Description#Instructions
Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.

The scope encompasses all topics related to the molecular and cellular pathophysiology of metabolic diseases like obesity, type 2 diabetes and the metabolic syndrome, and their associated complications.

Clinical studies are considered as an integral part of the Journal and should be related to one of the following topics:
  • the dysregulation of hormone receptors and signal transduction
  • the contribution of gene variants and gene regulatory processes
  • the impairment of intermediary metabolism at the cellular level
  • secretion and metabolism of peptides and other factors that mediate cellular crosstalk
  • therapeutic strategies for managing metabolic diseases

Special issues dedicated to topics in the field will be published regularly.





Read More: http://informahealthcare.com/page/arp/Description#Instructions
Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.




Read More: http://informahealthcare.com/page/arp/Description#Instructions

Journal cover

Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.


Instructions to Authors

Instructions for Authors

All submissions should be made online at Archives of Physiology & Biochemistry ScholarOne Manuscripts site.

New users must first create an account. Once a user is logged onto the site, submissions should be made via the Author Centre. If you are a new author but have previously reviewed for Archives of Physiology & Biochemistry  through the online system, you should use your existing reviewer username and password to log in as an author.

For assistance with any aspect of the site, please refer to the User Guide which is accessed via the 'Get Help Now' button at the top right of every screen.

A covering letter or email should be included indicating that the submission is made on behalf of all authors, although it is not necessary for each author to sign the letter (see section below for further details on authorship). On receipt, the manuscript will be immediately acknowledged by email.

Download the
Instructions for Authors for detailed notes on how to prepare your manuscript.

The following issues must be addressed by authors submitting manuscripts to Archives of Physiology & Biochemistry:

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This information must be stated in the manuscript, after the main text under a subheading "Declaration of interest". If there is a conflict of interest, this must also be indicated in the appropriate field during the submission process. Please click on
Declaration of Interest statement for further information.

All research submissions should include information about approval by the relevant research ethics board. Please click on
Ethics and Consent for further information.

All authors must comply with the following polices. Please click on the below links for more information.

Authorship, Submissions, Plagiarism and Peer Review

Clinical Trials Registry

Copyright and Permissions

For more author resources, including NIH and Wellcome Trust policies click here.

If your article is accepted, it will be forwarded to the Publisher for publication. Please click for information on
Proofs, Reprints and Colour Figures.








Read More: http://informahealthcare.com/page/arp/Description#Instructions

Instructions for Authors

All submissions should be made online at Archives of Physiology & Biochemistry ScholarOne Manuscripts site.

New users must first create an account. Once a user is logged onto the site, submissions should be made via the Author Centre. If you are a new author but have previously reviewed for Archives of Physiology & Biochemistry  through the online system, you should use your existing reviewer username and password to log in as an author.

For assistance with any aspect of the site, please refer to the User Guide which is accessed via the 'Get Help Now' button at the top right of every screen.

A covering letter or email should be included indicating that the submission is made on behalf of all authors, although it is not necessary for each author to sign the letter (see section below for further details on authorship). On receipt, the manuscript will be immediately acknowledged by email.

Download the
Instructions for Authors for detailed notes on how to prepare your manuscript.

The following issues must be addressed by authors submitting manuscripts to Archives of Physiology & Biochemistry:

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This information must be stated in the manuscript, after the main text under a subheading "Declaration of interest". If there is a conflict of interest, this must also be indicated in the appropriate field during the submission process. Please click on
Declaration of Interest statement for further information.

All research submissions should include information about approval by the relevant research ethics board. Please click on
Ethics and Consent for further information.

All authors must comply with the following polices. Please click on the below links for more information.

Authorship, Submissions, Plagiarism and Peer Review

Clinical Trials Registry

Copyright and Permissions

For more author resources, including NIH and Wellcome Trust policies click here.

If your article is accepted, it will be forwarded to the Publisher for publication. Please click for information on
Proofs, Reprints and Colour Figures.








Read More: http://informahealthcare.com/page/arp/Description#Instructions

Instructions for Authors

All submissions should be made online at Archives of Physiology & Biochemistry ScholarOne Manuscripts site.

New users must first create an account. Once a user is logged onto the site, submissions should be made via the Author Centre. If you are a new author but have previously reviewed for Archives of Physiology & Biochemistry  through the online system, you should use your existing reviewer username and password to log in as an author.

For assistance with any aspect of the site, please refer to the User Guide which is accessed via the 'Get Help Now' button at the top right of every screen.

A covering letter or email should be included indicating that the submission is made on behalf of all authors, although it is not necessary for each author to sign the letter (see section below for further details on authorship). On receipt, the manuscript will be immediately acknowledged by email.

Download the Instructions for Authors for detailed notes on how to prepare your manuscript.

The following issues must be addressed by authors submitting manuscripts to Archives of Physiology & Biochemistry:

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This information must be stated in the manuscript, after the main text under a subheading "Declaration of interest". If there is a conflict of interest, this must also be indicated in the appropriate field during the submission process. Please click on Declaration of Interest statement for further information.

All research submissions should include information about approval by the relevant research ethics board. Please click on Ethics and Consent for further information.

All authors must comply with the following polices. Please click on the below links for more information.

Authorship, Submissions, Plagiarism and Peer Review

Clinical Trials Registry

Copyright and Permissions

For more author resources, including NIH and Wellcome Trust policies click here.

If your article is accepted, it will be forwarded to the Publisher for publication. Please click for information on Proofs, Reprints and Colour Figures.


Editorial Board
EDITOR IN CHIEF

Professor Jürgen Eckel

German Diabetes Center
Paul-Langerhans-Group Integrative Physiology
Düsseldorf
Germany


ASSOCIATE EDITORS

Stefan Engeli - Hannover Medical School, Institute of Clinical Pharmacology, Hannover, Germany
Ton Maassen - Leiden University, Medical Centre, Department of Molecular Cell Biology, Leiden, The Netherlands
Cristina M Rondinone - Hoffmann-La Roche, Department of Metabollic Diseases, Nutley, NJ, USA
Shlomo Sasson - The Hebrew University, School of Medicine, Jerusalem, Israel
Peter Shepherd - The University of Auckland, School of Medical Sciences, Department of Molecular Medicine & Pathology, Auckland, New Zealand


EDITORIAL BOARD

Marisa Bonsignore - University of Palermo, Biomedical Dept. of Internal Specialist Medicine, Section of Pulmonology, Palermo, Italy
Aldona Dembińska-Kieć - Jagiellonian University, Department of Clinical Biochemistry, Kraków, Poland
Chidum Ezenwaka - The University of the West Indies, Department of Para-Clinical Sciences, Faculty of Medical Sciences St Augustine,Trinidad and Tobago
Erik Henriksen - University of Arizona, Department of Physiology, Tucson, AZ, USA
Jørgen Jensen - Norwegian School of Sports Sciences, Department of Physical Performance, Oslo, Norway
Hannah Kanety - Chaim Sheba Medical Center, Institute of Endocrinology, Tel-Hashomer, Israel
Daniel Konrad - University Children's Hospital, Division of Endocrinology and Diabetology, Zürich, Switzerland
Joost Luiken - Cardiovascular Research Institute Maastricht (CARIM), Department of Physiology, Maastricht, The Netherlands
Günter Müller - Sanofi-Aventis Germany GmbH, Research & Development, Therapeutic Department Metabolism, Frankfurt, Germany
Markus Niessen - University of Zürich Hospital, Department of Endocrinology and Diabetology, Zürich, Switzerland
Sebastio Perrini - University of Bari, Department of Emergency and Organ Transplantation, Section on Internal Medicine, Endocrinology, Andrology, and Metabollic Diseases, Bari, Italy
Doina Popov - Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest, Romania
Nasser Rizk - Qatar University, Faculty of Science, Doha, Qatar
Annette Schürmann - German Institute of Human Nutrition (DIfE), Department-Experimental Diabetology, Potsdam, Germany
Henrike Sell - German Diabetes Center, Paul-Langerhans Group Integrative Physiology, Düsseldorf, Germany



Read More: http://informahealthcare.com/page/arp/EditorialAdvisoryBoard

EDITOR IN CHIEF

Professor Jürgen Eckel

German Diabetes Center
Paul-Langerhans-Group Integrative Physiology
Düsseldorf
Germany


ASSOCIATE EDITORS

Stefan Engeli - Hannover Medical School, Institute of Clinical Pharmacology, Hannover, Germany
Ton Maassen - Leiden University, Medical Centre, Department of Molecular Cell Biology, Leiden, The Netherlands
Cristina M Rondinone - Hoffmann-La Roche, Department of Metabollic Diseases, Nutley, NJ, USA
Shlomo Sasson - The Hebrew University, School of Medicine, Jerusalem, Israel
Peter Shepherd - The University of Auckland, School of Medical Sciences, Department of Molecular Medicine & Pathology, Auckland, New Zealand


EDITORIAL BOARD

Marisa Bonsignore - University of Palermo, Biomedical Dept. of Internal Specialist Medicine, Section of Pulmonology, Palermo, Italy
Aldona Dembińska-Kieć - Jagiellonian University, Department of Clinical Biochemistry, Kraków, Poland
Chidum Ezenwaka - The University of the West Indies, Department of Para-Clinical Sciences, Faculty of Medical Sciences St Augustine,Trinidad and Tobago
Erik Henriksen - University of Arizona, Department of Physiology, Tucson, AZ, USA
Jørgen Jensen - Norwegian School of Sports Sciences, Department of Physical Performance, Oslo, Norway
Hannah Kanety - Chaim Sheba Medical Center, Institute of Endocrinology, Tel-Hashomer, Israel
Daniel Konrad - University Children's Hospital, Division of Endocrinology and Diabetology, Zürich, Switzerland
Joost Luiken - Cardiovascular Research Institute Maastricht (CARIM), Department of Physiology, Maastricht, The Netherlands
Günter Müller - Sanofi-Aventis Germany GmbH, Research & Development, Therapeutic Department Metabolism, Frankfurt, Germany
Markus Niessen - University of Zürich Hospital, Department of Endocrinology and Diabetology, Zürich, Switzerland
Sebastio Perrini - University of Bari, Department of Emergency and Organ Transplantation, Section on Internal Medicine, Endocrinology, Andrology, and Metabollic Diseases, Bari, Italy
Doina Popov - Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest, Romania
Nasser Rizk - Qatar University, Faculty of Science, Doha, Qatar
Annette Schürmann - German Institute of Human Nutrition (DIfE), Department-Experimental Diabetology, Potsdam, Germany
Henrike Sell - German Diabetes Center, Paul-Langerhans Group Integrative Physiology, Düsseldorf, Germany



Read More: http://informahealthcare.com/page/arp/EditorialAdvisoryBoard

 



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有